Bowel Resection at the Time of Primary Debulking for Epithelial Ovarian Carcinoma: Outcomes in Patients Treated with Platinum and Taxane-Based Chemotherapy

Journal of the American College of Surgeons

Volumn 203, Issue 4, 2006, Pages 527-532

  Estes, Jacob M ^a   Leath III, Charles A ^a   Straughn Jr , J Michael ^a   Rocconi, Rodney P ^a   Kirby, Tyler O ^a   Huh, Warner K ^a   Barnes III, Mack N ^a  

^a University of Alabama   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLATINUM DERIVATIVE; TAXANE DERIVATIVE;

ADULT; ADVANCED CANCER; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DEMOGRAPHY; ENTEROCUTANEOUS FISTULA; FEMALE; HISTOPATHOLOGY; HUMAN; INTESTINE SURGERY; OVARY CARCINOMA; PELVIS ABSCESS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMALL INTESTINE OBSTRUCTION; STATISTICAL ANALYSIS; STROKE; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INTESTINES; MIDDLE AGED; OVARIAN NEOPLASMS; PLATINUM COMPOUNDS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TAXOIDS; TREATMENT OUTCOME;

EID: 33748771187     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2006.06.019     Document Type: Article

References (21)

1. Jemal A., Murray T., Ward E., et al. Cancer statistics, 2005. CA Cancer J Clin 55 (2005) 10-30
2. Ozols R.F., Bundy B.N., Greer B.E., et al. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol 21 (2003) 3194-3200
3. Bookman M.A., McGuire III W.P., Kilpatrick D., et al. Carboplatin and paclitaxel in ovarian carcinoma: a phase I study of the Gynecologic Oncology Group. J Clin Oncol 14 (1996) 1895-1902
4. McGuire W.P., Hoskins W.J., Brady M.F., et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 334 (1996) 1-6
5. Bristow R.E., Tomacruz R.S., Armstrong D.K., et al. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20 (2002) 1248-1259
6. Covens A.L. A critique of surgical cytoreduction in advanced ovarian cancer. Gynecol Oncol 78 (2000) 269-274
7. Hoskins W.J., McGuire W.P., Brady M.F., et al. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol 170 (1994) 974-979 discussion 979-980
8. Chi D.S., Liao J.B., Leon L.F., et al. Identification of prognostic factors in advanced epithelial ovarian carcinoma. Gynecol Oncol 82 (2001) 532-537
9. Le T., Krepart G.V., Lotocki R.J., and Heywood M.S. Does debulking surgery improve survival in biologically aggressive ovarian carcinoma?. Gynecol Oncol 67 (1997) 208-214
10. Eisenkop S.M., and Spirtos N.M. Procedures required to accomplish complete cytoreduction of ovarian cancer: is there a correlation with "biological aggressiveness" and survival?. Gynecol Oncol 82 (2001) 435-441
11. Chi D.S., Franklin C.C., Levine D.A., et al. Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach. Gynecol Oncol 94 (2004) 650-654
12. Cliby W., Dowdy S., Feitoza S.S., et al. Diaphragm resection for ovarian cancer: technique and short-term complications. Gynecol Oncol 94 (2004) 655-660
13. Gillette-Cloven N., Burger R.A., Monk B.J., et al. Bowel resection at the time of primary cytoreduction for epithelial ovarian cancer. J Am Coll Surg 193 (2001) 626-632
14. Thigpen T. The if and when of surgical debulking for ovarian carcinoma. N Engl J Med 351 (2004) 2544-2546
15. Mourton S.M., Temple L.K., Abu-Rustum N.R., et al. Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer. Gynecol Oncol 99 (2005) 608-614
16. Weber A.M., and Kennedy A.W. The role of bowel resection in the primary surgical debulking of carcinoma of the ovary. J Am Coll Surg 179 (1994) 465-470
17. Berek J.S., Hacker N.F., and Lagasse L.D. Rectosigmoid colectomy and reanastomosis to facilitate resection of primary and recurrent gynecologic cancer. Obstet Gynecol 64 (1984) 715-720
18. Castaldo T.W., Petrilli E.S., Ballon S.C., and Lagasse L.D. Intestinal operations in patients with ovarian carcinoma. Am J Obstet Gynecol 139 (1981) 80-84
19. Eisenkop S.M., Nalick R.H., and Teng N.N. Modified posterior exenteration for ovarian cancer. Obstet Gynecol 78 (1991) 879-885
20. Soper J.T., Couchman G., Berchuck A., and Clarke-Pearson D. The role of partial sigmoid colectomy for debulking epithelial ovarian carcinoma. Gynecol Oncol 41 (1991) 239-244
21. Tamussino K.F., Lim P.C., Webb M.J., et al. Gastrointestinal surgery in patients with ovarian cancer. Gynecol Oncol 80 (2001) 79-84